{"disease":{"id":"aids-related-primary-effusion-lymphoma","name":"aids related primary effusion lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01193842","title":"Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT02823327","title":"Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma","phase":"","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT02337985","title":"Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT01961063","title":"Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"City of Hope Medical Center","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}